MGP Ingredients vs Martin Midstream Partners L.P.
CASK and MMLP side by side, both in wholesale trade-non-durable goods. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CASK and MMLP compare
MGP Ingredients is the larger company, worth 4.9 times as much as Martin Midstream Partners L.P. ($375M against $77.1M).
Martin Midstream Partners L.P. grew revenue faster over the last twelve months (13.2% versus −15.9% for MGP Ingredients).
Martin Midstream Partners L.P. keeps more of each dollar of sales as profit, with a net margin of −1.4% compared with −51.4% at MGP Ingredients.
Both pay dividends: MGP Ingredients yields 2.7% and Martin Midstream Partners L.P. 1.3%.
Martin Midstream Partners L.P. scores higher on the StockData Score (6 against 5 for MGP Ingredients), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CASK | MMLP |
|---|---|---|
| Size and price | ||
| Market cap | $375M | $77.1M |
| Share price | $17.52 | $1.97 |
| Change, 1 year | −29.5% | −23.2% |
| Change, 5 years | −76.1% | −37.1% |
| Beta (5Y) | 0.68 | 0.43 |
| Employees | 617 | 1,723 |
| StockData Score | ||
| Total score | 5 | 6 (better) |
| Valuation score | 3 | 3 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 0 |
| Health score | 1 | 1 |
| Dividend score | 1 | 1 |
| Valuation | ||
| P/S | 0.8× | 0.1× (better) |
| P/B | 0.6× | – |
| EV/EBITDA | – | 5.4× |
| P/FCF | 712× | – |
| FCF yield | 0.14% (better) | −24.2% |
| Fair value | $43.03 | $17.33 |
| Margin of safety | 59.3% | 88.6% (better) |
| Growth | ||
| Revenue growth (TTM) | −15.9% | 13.2% (better) |
| Revenue growth, 5Y average | 6.3% (better) | 1.3% |
| Profitability | ||
| Gross margin | 34.7% | 50.6% (better) |
| Operating margin | −57.2% | 6.2% (better) |
| Net margin | −51.4% | −1.4% (better) |
| FCF margin | 0.11% (better) | −2.3% |
| Return on equity | −34.5% | – |
| Return on invested capital | −21.6% | – |
| Financial health | ||
| Debt / equity | 0.57 | – |
| Net debt / EBITDA | – | 4.69 |
| Interest coverage | – | 0.9× |
| Current ratio | 6.91 (better) | 1.35 |
| Altman Z-score | 1.04 | 1.90 (better) |
| Piotroski F-score | 4 (better) | 2 |
| Dividends and buybacks | ||
| Dividend yield | 2.7% (better) | 1.3% |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 0.00% | – |
| Buyback yield | 0.25% | – |
| Shareholder yield | 3.0% (better) | 1.3% |
| Ownership | ||
| Held by institutions | 72.3% | 44.3% |
| Held by insiders | 75.3% | 66.7% |
| Insider net buying, 12 months | −$9.6M | $75.5K (better) |
| Short interest, % of float | – | 0.71% |
Go deeper
- CASK stock overview
- CASK income statement
- CASK valuation and score
- MMLP stock overview
- MMLP income statement
- MMLP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.